Al Za’abi et al. suggested that metformin could attenuate the progression of CKD in both diabetic and non-diabetic rats by alleviating inflammation and apoptosis through the inhibition of NF-κB signaling [42]. This evidence concerns the gene NFKB1 and chronic kidney disease.